发明名称 IMPROVED TRANSDERMAL DELIVERY SYSTEM FOR THE ADMINISTRATION OF ROTIGOTINE.
摘要 <p>An improved Transdermal Delivery System (TDS) comprising a backing layer inert to the components of the matrix, a self-adhesive matrix containing rotigotine and a protective foil or sheet to be removed prior to use, characterized in that the self-adhesive matrix consists of a solid or semi-solid semi-permeable polymer (1) wherein rotigotine in its free base form has been incorporated, (2) which is saturated with rotigotine and contains said rotigotine as a multitude of microreservoirs within the matrix, (3) which is highly permeable for the free base of rotigotine, (4) which is impermeable for the protonated form of rotigotine, (5) wherein the maximum diameter of the microreservoirs is less than the thickness of the matrix. is provided. Said TDS provides for enhanced flux of rotigotine across the TDS/skin interface.</p>
申请公布号 MXPA05000350(A) 申请公布日期 2005.03.31
申请号 MX2005PA00350 申请日期 2003.07.28
申请人 SCHWARZ PHARMA AG 发明人 WOLFF, HANS-MICHAEL
分类号 C07D333/20;A61K9/70;A61K31/38;A61K31/381;A61K47/24;A61P25/16;A61P43/00;(IPC1-7):A61K31/38 主分类号 C07D333/20
代理机构 代理人
主权项
地址